Correlation Between CTi Biopharma and Affimed NV
Can any of the company-specific risk be diversified away by investing in both CTi Biopharma and Affimed NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTi Biopharma and Affimed NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CTi Biopharma Corp and Affimed NV, you can compare the effects of market volatilities on CTi Biopharma and Affimed NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTi Biopharma with a short position of Affimed NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTi Biopharma and Affimed NV.
Diversification Opportunities for CTi Biopharma and Affimed NV
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between CTi and Affimed is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding CTi Biopharma Corp and Affimed NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Affimed NV and CTi Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTi Biopharma Corp are associated (or correlated) with Affimed NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Affimed NV has no effect on the direction of CTi Biopharma i.e., CTi Biopharma and Affimed NV go up and down completely randomly.
Pair Corralation between CTi Biopharma and Affimed NV
If you would invest 909.00 in CTi Biopharma Corp on September 13, 2024 and sell it today you would earn a total of 0.00 from holding CTi Biopharma Corp or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 1.59% |
Values | Daily Returns |
CTi Biopharma Corp vs. Affimed NV
Performance |
Timeline |
CTi Biopharma Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Affimed NV |
CTi Biopharma and Affimed NV Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CTi Biopharma and Affimed NV
The main advantage of trading using opposite CTi Biopharma and Affimed NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTi Biopharma position performs unexpectedly, Affimed NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affimed NV will offset losses from the drop in Affimed NV's long position.CTi Biopharma vs. Rigel Pharmaceuticals | CTi Biopharma vs. Fortress Biotech | CTi Biopharma vs. Reviva Pharmaceuticals Holdings | CTi Biopharma vs. Protalix Biotherapeutics |
Affimed NV vs. Pieris Pharmaceuticals | Affimed NV vs. ADC Therapeutics SA | Affimed NV vs. Agenus Inc | Affimed NV vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
CEOs Directory Screen CEOs from public companies around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data |